@misc{misc, title  = {{The cost-effectiveness of expanding the NHS newborn bloodspot screening programme to include homocystinuria (HCU), maple syrup urine disease (MSUD), glutaric aciduria type 1 (GA1), isovaleric acidaemia (IVA), and long-chain hydroxyl acyl-CoA dehydrogenase deficiency (LCHADD) (2014)}},

 url = {{}},

 year = {{-0001}},

 month = {{11}},

 author = {{Bessey A and Chilcott J and Paisley S and Pandor A}},

 note = {{Accessed on 2024/10/19}}}